Terazosin Hcl

   
Google
 
Web NewDrugInformation.com

Terazosin Hcl


Drug - Terazosin Hcl
The trade name of the product as shown on the labeling.

Dosage - CAPSULE; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Terazosin Hydrochloride
Multiple ingredients are in alphabetical order.

Strength - EQ 2MG BASE
The potency of the active ingredient(s), Terazosin Hydrochloride. May repeat for multiple part products.

Applicant - SANDOZ
The firm name holding legal responsibility for Terazosin Hcl. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 075667
The FDA assigned number to Terazosin Hcl. Format is nnnnnn.

Product Number - 002
The FDA assigned number to identify Terazosin Hcl. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AB
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Jul 28, 2000
The date Terazosin Hcl was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Terazosin Hcl. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Terazosin Hcl is in. Format is RX, OTC, DISCN.

Applicant Full Name - Sandoz Inc
The full name of the firm holding legal responsibility for the new application of Terazosin Hcl.

Terazosin Hcl